Skip to content

Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative

Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03114579
Acronym
NEXFIN
Enrollment
42
Registered
2017-04-14
Start date
2015-02-11
Completion date
2017-02-11
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Output, Peroperative

Brief summary

Continuous perioperative cardiac output (DC) and blood pressure (PA) monitoring contributes to hemodynamic stability and ensures adequate perfusion pressure, resulting in a reduction in morbidity and mortality and length of hospital stay. The monitors usually used in perioperative are either semi-invasive and difficult for calibration (oesophageal Doppler) or invasive (arterial catheter). The Nexfin HD allows these two measurements and it is completely non-invasive, remains to validate its use in peroperative.

Interventions

DEVICEIntraoperative heart rate measurement (reference method)

Measurement of cardiac output by both monitors: NEXFIN HD and oesophageal doppler, blood pressure measurement by the catheter and NEXFIN HD monitor, and cardiac output and blood pressure measurements after treatment administration (vasoconstrictor or filling)

DEVICENEXFIN HD

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients candidate for surgery under general anesthesia requiring oesophageal Doppler or arterial catheter hemodynamic monitoring.

Exclusion criteria

* Patients with cardiac and thoracic surgery, * patients for whom access to the head is impossible, * facial trauma patients, * patients with aortic malformation, dilation or coarctation, * patients with aortic dissection, * patients with vascular surgery with aortic clamping, * patients with a tumor, stenosis or varices of the esophagus, * patients with severe oesophagitis, * patients with thoracic radiotherapy * patients under guardianship or curatorship or deprived of liberty.

Design outcomes

Primary

MeasureTime frame
Overall survival defines as the time between the date of surgery and death or date of last news6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026